Trials / Completed
CompletedNCT06589791
A Disease Area Study on the Awareness and Perceptions of Systemic Inflammation and hsCRP as a biomARKer in Patients With ASCVD and CKD in China Among Cardiologists and Nephrologists
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,500 (actual)
- Sponsor
- Novo Nordisk A/S · Industry
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This is a survey-based study with the objective to understand the awareness, perceptions and potential clinical management patterns among Chinese cardiologists and nephrologists towards the role of systemic inflammation in patients with ASCVD and CKD in real-world clinical setting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No treatment given | Online self-completion survey |
Timeline
- Start date
- 2024-09-09
- Primary completion
- 2024-12-05
- Completion
- 2024-12-05
- First posted
- 2024-09-19
- Last updated
- 2025-12-05
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06589791. Inclusion in this directory is not an endorsement.